Send the following on WhatsApp
Continue to ChatNovoCure, the Israeli tumor specialist announces NASDAQ €170M IPO on Labiotech.eu https://www.labiotech.eu/trends-news/novocure-the-israeli-tumor-specialist-announces-nasdaq-ipo/
NovoCure, the Israeli tumor specialist announces NASDAQ €170M IPO on Labiotech.eu https://www.labiotech.eu/trends-news/novocure-the-israeli-tumor-specialist-announces-nasdaq-ipo/